Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Preclinical antiinflammatory effects demonstrated for CT-3

Nov. 13, 1997

Minocycline associated with marked long-term efficacy in early RA

Nov. 13, 1997

Promising clinical results reported for Avakine

Nov. 13, 1997

New class of TNF-alpha inhibitors safe and well tolerated in phase I

Nov. 12, 1997

rhIL-1ra provides long-term improvement in RA

Nov. 11, 1997

Clinical results reported for leflunomide in refractory RA and Wegener's granulomatosis

Nov. 11, 1997

Humanized anti-CD4 MAb suppresses synovial inflammation/cytokine levels

Nov. 11, 1997

MK-966 assessed in large trial in osteoarthritis of the knee and hip

Nov. 11, 1997

TNF/PDE inhibitors disclosed by Rhone-Poulenc Rorer

Nov. 6, 1997

MMP inhibitors reported by ProScript

Nov. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...